SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19424036
Source:
http://linkedlifedata.com/resource/pubmed/id/19424036
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0596545
,
umls-concept:C0678756
,
umls-concept:C0805586
,
umls-concept:C1521840
,
umls-concept:C2603343
pubmed:issue
9
pubmed:dateCreated
2009-5-8
pubmed:abstractText
The Symphony study compared four immunosuppressant regimens, defined by protocol-specified target drug concentrations. This subanalysis examines actual drug levels and the implications on the interpretation of results.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0132144
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenal Cortex Hormones
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus
,
http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus
,
http://linkedlifedata.com/resource/pubmed/chemical/daclizumab
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1534-6080
pubmed:author
pubmed-author:DalozePierreP
,
pubmed-author:EkbergHenrikH
,
pubmed-author:MamelokRichard DRD
,
pubmed-author:PearsonThomas CTC
,
pubmed-author:Tedesco-SilvaHélioH
,
pubmed-author:VincentiFlavioF
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1360-6
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19424036-Adrenal Cortex Hormones
,
pubmed-meshheading:19424036-Antibodies, Monoclonal
,
pubmed-meshheading:19424036-Antibodies, Monoclonal, Humanized
,
pubmed-meshheading:19424036-Cadaver
,
pubmed-meshheading:19424036-Clinical Trials as Topic
,
pubmed-meshheading:19424036-Cyclosporine
,
pubmed-meshheading:19424036-Dose-Response Relationship, Drug
,
pubmed-meshheading:19424036-Drug Therapy
,
pubmed-meshheading:19424036-Humans
,
pubmed-meshheading:19424036-Immunoglobulin G
,
pubmed-meshheading:19424036-Immunosuppressive Agents
,
pubmed-meshheading:19424036-Kidney Transplantation
,
pubmed-meshheading:19424036-Living Donors
,
pubmed-meshheading:19424036-Research Design
,
pubmed-meshheading:19424036-Sirolimus
,
pubmed-meshheading:19424036-Tacrolimus
,
pubmed-meshheading:19424036-Tissue Donors
pubmed:year
2009
pubmed:articleTitle
The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study.
pubmed:affiliation
Department of Nephrology and Transplantation, University Hospital, Lund University, Malmö, Sweden. henrik.ekberg@med.lu.se
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't